Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma

Article

Abstract: NeuGc-containing gangliosides have been described in melanoma cells and are an attractive target for

Palabras claves:

Clinical trial, Ganglioside, melanoma, N-glycolyl GM3, Therapeutic vaccine

Autores:

Ávila Y., Carmen Elena Viada, Carr A., Cepeda M., De La Torre A.V., Fernandez L.E., Gracia E., Hernandez J., Osorio M., Pérez K., Reigosa E., Rodríguez M., Saurez G.

Fuentes:

scopus